statistiche ricercatore

Continente	#
NA - Nord America	459
AS - Asia	437
EU - Europa	432
SA - Sud America	39
Continente sconosciuto - Info sul continente non disponibili	36
AF - Africa	13
OC - Oceania	4
Totale	1.420

Nazione	#
US - Stati Uniti d'America	437
DE - Germania	190
SG - Singapore	135
CN - Cina	111
IT - Italia	79
BD - Bangladesh	57
HK - Hong Kong	39
SE - Svezia	39
VN - Vietnam	37
BR - Brasile	31
GB - Regno Unito	31
RU - Federazione Russa	26
FR - Francia	19
IN - India	16
NL - Olanda	14
TR - Turchia	14
CA - Canada	13
FI - Finlandia	11
IE - Irlanda	10
ID - Indonesia	6
CI - Costa d'Avorio	5
IQ - Iraq	5
JP - Giappone	5
ES - Italia	4
KR - Corea	4
IL - Israele	3
MT - Malta	3
MX - Messico	3
UA - Ucraina	3
AR - Argentina	2
AU - Australia	2
CL - Cile	2
KE - Kenya	2
NZ - Nuova Zelanda	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
BB - Barbados	1
BM - Bermuda	1
CR - Costa Rica	1
CY - Cipro	1
DZ - Algeria	1
EC - Ecuador	1
EG - Egitto	1
JM - Giamaica	1
KG - Kirghizistan	1
MA - Marocco	1
OM - Oman	1
PA - Panama	1
PE - Perù	1
PT - Portogallo	1
PY - Paraguay	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
TT - Trinidad e Tobago	1
VE - Venezuela	1
Totale	1.384

Nome	#
Pathological and clinical features of enteric adenocarcinoma of the thymus. A pooled analysis of cases from a reference center and systematic review of the literature	268
Thymic carcinoma with Lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapy	232
High-Dose Ifosfamide for advanced thymic epithelial tumors (TETs): a TYME network study	231
Complex differential diagnosis between primary breast cancer and breast metastasis from egfr-mutated lung adenocarcinoma: Case report and literature review	198
Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naive patients with advanced non-small-cell lung cancer	184
Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials	158
Reply to the article “Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity” by V. R. Rozados et al. (Ann Oncol 2004; 15: 1543–1550): ... and in humans?	137
Safety of mRNA-COVID-19 Vaccines in Patients With Thoracic Cancers	11
Gemcitabine-induced progressive and sustained tumour response in a patient with multi-drug resistant uterine leiomyosarcoma	1
Totale	1.420

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	72	0	9	3	6	9	3	3	8	7	4	5	15
2022/2023	108	19	15	11	8	9	20	0	3	17	1	3	2
2023/2024	182	10	4	3	8	15	10	25	23	9	20	27	28
2024/2025	306	28	28	25	32	10	13	13	17	14	24	31	71
2025/2026	592	61	50	65	39	51	25	76	16	45	31	64	69
2026/2027	60	31	29	0	0	0	0	0	0	0	0	0	0
Totale													1.420

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca